Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Effect of operative local anesthesia on postoperative pain outcomes of inflatable penile prosthesis: prospective comparison of two medications.

Xie D, Nicholson M, Azaiza M, Gheiler V, Lopez I, Nehrenz GM, Klopukh B, Bianco FJ, Perito P, Gheiler E.

Int J Impot Res. 2018 Jun;30(3):93-96. doi: 10.1038/s41443-018-0025-7. Epub 2018 May 25.

PMID:
29795532
2.

A prospective evaluation of penile measures and glans penis sensory changes after penile prosthetic surgery.

Xie D, Nicholas M, Gheiler V, Perito D, Siano L, Kislinger I, Nehrenz GM, Klopukh B, Bianco FJ, Perito P, Gheiler E.

Transl Androl Urol. 2017 Jun;6(3):529-533. doi: 10.21037/tau.2017.05.34.

3.

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.

Gore JL, du Plessis M, Santiago-Jiménez M, Yousefi K, Thompson DJS, Karsh L, Lane BR, Franks M, Chen DYT, Bandyk M, Bianco FJ Jr, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW.

Cancer. 2017 Aug 1;123(15):2850-2859. doi: 10.1002/cncr.30665. Epub 2017 Apr 19.

4.

Focalyx Dx, Bx, Tx et Apps: A novel contemporary fusion paradigm for the management of prostate cancer.

Bianco FJ, Martínez-Salamanca JI.

Arch Esp Urol. 2016 Jul;69(6):353-63. Review.

PMID:
27416639
5.

Impact of the Cell Cycle Progression Test on Physician and Patient Treatment Selection for Localized Prostate Cancer.

Shore ND, Kella N, Moran B, Boczko J, Bianco FJ, Crawford ED, Davis T, Roundy KM, Rushton K, Grier C, Kaldate R, Brawer MK, Gonzalgo ML.

J Urol. 2016 Mar;195(3):612-8. doi: 10.1016/j.juro.2015.09.072. Epub 2015 Sep 25.

PMID:
26403586
6.

Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ Jr, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ.

Eur Urol. 2015 Jun;67(6):1160-1167. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6.

7.

A randomized, double-blind, solifenacin succinate versus placebo control, phase 4, multicenter study evaluating urinary continence after robotic assisted radical prostatectomy.

Bianco FJ, Albala DM, Belkoff LH, Miles BJ, Peabody JO, He W, Bradt JS, Haas GP, Ahlering TE.

J Urol. 2015 Apr;193(4):1305-10. doi: 10.1016/j.juro.2014.09.106. Epub 2014 Oct 2.

PMID:
25281778
8.

The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications.

Ramos JA, Bianco FJ.

Indian J Urol. 2012 Jan;28(1):9-14. doi: 10.4103/0970-1591.94942.

9.

Oncocytoma of the adrenal gland medulla.

Chisté M, Poppiti RJ, Bianco FJ.

Ann Diagn Pathol. 2013 Feb;17(1):123-6. doi: 10.1016/j.anndiagpath.2011.07.002. Epub 2011 Nov 4.

PMID:
22056038
10.

Robotic radical prostatectomy: present and future.

Bianco FJ.

Arch Esp Urol. 2011 Oct;64(8):839-46. Review. English, Spanish.

PMID:
22052765
11.

Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis.

Shariat SF, Scherr DS, Gupta A, Bianco FJ Jr, Karakiewicz PI, Zeltser IS, Samadi DB, Akhavan A.

Arch Esp Urol. 2011 Oct;64(8):681-94. Review. English, Spanish.

PMID:
22052751
12.

Posterior rhabdosphincter reconstruction during robotic assisted radical prostatectomy: results from a phase II randomized clinical trial.

Sutherland DE, Linder B, Guzman AM, Hong M, Frazier HA 2nd, Engel JD, Bianco FJ Jr.

J Urol. 2011 Apr;185(4):1262-7. doi: 10.1016/j.juro.2010.11.085. Epub 2011 Feb 22.

PMID:
21334025
13.

Prognostic impact of the 2009 UICC/AJCC TNM staging system for renal cell carcinoma with venous extension.

Martínez-Salamanca JI, Huang WC, Millán I, Bertini R, Bianco FJ, Carballido JA, Ciancio G, Hernández C, Herranz F, Haferkamp A, Hohenfellner M, Hu B, Koppie T, Martínez-Ballesteros C, Montorsi F, Palou J, Pontes JE, Russo P, Terrone C, Villavicencio H, Volpe A, Libertino JA; International Renal Cell Carcinoma-Venous Thrombus Consortium.

Eur Urol. 2011 Jan;59(1):120-7. doi: 10.1016/j.eururo.2010.10.001. Epub 2010 Oct 13.

PMID:
20980095
14.

Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience.

Vickers AJ, Savage CJ, Bianco FJ, Klein EA, Kattan MW, Secin FP, Guilloneau BD, Scardino PT.

Int J Cancer. 2011 Apr 1;128(7):1697-702. doi: 10.1002/ijc.25502. Epub 2010 Jun 9.

15.

Fellowship training as a modifier of the surgical learning curve.

Bianco FJ, Cronin AM, Klein EA, Pontes JE, Scardino PT, Vickers AJ.

Acad Med. 2010 May;85(5):863-8. doi: 10.1097/ACM.0b013e3181d73a45.

16.
17.

Variations among experienced surgeons in cancer control after open radical prostatectomy.

Bianco FJ Jr, Vickers AJ, Cronin AM, Klein EA, Eastham JA, Pontes JE, Scardino PT.

J Urol. 2010 Mar;183(3):977-82. doi: 10.1016/j.juro.2009.11.015. Epub 2010 Jan 18.

18.

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ Jr, Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT.

J Clin Oncol. 2009 Sep 10;27(26):4300-5. doi: 10.1200/JCO.2008.18.2501. Epub 2009 Jul 27.

19.

Pelvic neuroanatomy and radical prostatectomy with neurovascular preservation: quo vadis?

Martínez-Salamanca JI, Bianco FJ Jr, Secín FP, Carballido JA.

Eur Urol. 2009 Dec;56(6):1092-3. doi: 10.1016/j.eururo.2009.05.006. Epub 2009 May 13. No abstract available.

PMID:
19473750
20.

Prevalence of erectile dysfunction in men screened for prostate cancer.

Bianco FJ Jr, McHone BR, Wagner K, King A, Burgess J, Patierno S, Jarrett TW.

Urology. 2009 Jul;74(1):89-93. doi: 10.1016/j.urology.2008.03.036. Epub 2009 May 9.

PMID:
19428072

Supplemental Content

Loading ...
Support Center